Tadashi Shimizu

Kobe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Anticancer Effects of Nortriptyline Hydrochloride in Osteosarcoma Cells Including Doxorubicin-resistant Cells.

Anticancer Effects of Nortriptyline Hydrochloride in Osteosarcoma Cells Including Doxorubicin-resistant Cells.

Journal: Anticancer research

Published: April 07, 2026

Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody-drug Conjugates Using Pharmacovigilance Databases.

Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody-drug Conjugates Using Pharmacovigilance Databases.

Journal: In vivo (Athens, Greece)

Published: April 06, 2026

Molecular signatures of triple-negative breast cancer cells acquiring palbociclib resistance via continuous exposure.

Molecular signatures of triple-negative breast cancer cells acquiring palbociclib resistance via continuous exposure.

Journal: Oncology letters

Published: February 13, 2026

Severe anemia as a risk factor in Japanese patients with ovarian cancer receiving olaparib: a retrospective study.

Severe anemia as a risk factor in Japanese patients with ovarian cancer receiving olaparib: a retrospective study.

Journal: BMC cancer

Published: February 06, 2026

Exploratory Analysis of Student Characteristics Contributing to Improved Learning Outcomes in Gamified Organic Chemistry Education.

Exploratory Analysis of Student Characteristics Contributing to Improved Learning Outcomes in Gamified Organic Chemistry Education.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: January 04, 2026

Cardiovascular Adverse Events Associated With Carfilzomib, Bortezomib, and Ixazomib: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database With Anticancer Agents as the Reference Group.

Cardiovascular Adverse Events Associated With Carfilzomib, Bortezomib, and Ixazomib: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database With Anticancer Agents as the Reference Group.

Journal: In vivo (Athens, Greece)

Published: November 22, 2025

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database.

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database.

Journal: In vivo (Athens, Greece)

Published: October 08, 2025

Impact of sodium-glucose cotransporter 2 (SGLT2) inhibitors on hematologic malignancy risk: Insights from Japanese claims data.

Impact of sodium-glucose cotransporter 2 (SGLT2) inhibitors on hematologic malignancy risk: Insights from Japanese claims data.

Journal: Journal of the National Cancer Institute

Published: May 27, 2025

Disproportionality Analysis of Intravitreal Ranibizumab, Aflibercept, and Brolucizumab for Cardiovascular and Cerebrovascular Events.

Disproportionality Analysis of Intravitreal Ranibizumab, Aflibercept, and Brolucizumab for Cardiovascular and Cerebrovascular Events.

Journal: Journal of clinical pharmacology

Published: May 18, 2025

Adverse events of antibody-drug conjugates: comparative analysis of agents with a common payload using the adverse event spontaneous reporting database.

Adverse events of antibody-drug conjugates: comparative analysis of agents with a common payload using the adverse event spontaneous reporting database.

Journal: The oncologist

Published: May 02, 2025

Effects of Azelastine on Glioblastoma Cells.

Effects of Azelastine on Glioblastoma Cells.

Journal: Anticancer research

Published: April 25, 2025

Comprehensive Analysis of Proteinuria and Nephrotic Syndrome Using the Japanese Adverse Drug Event Reporting Database.

Comprehensive Analysis of Proteinuria and Nephrotic Syndrome Using the Japanese Adverse Drug Event Reporting Database.

Journal: In vivo (Athens, Greece)

Published: April 05, 2025

Showing 1-12 of 109

Last Updated: 09/26/2026